SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-24-013645
Filing Date
2024-02-14
Accepted
2024-02-14 08:00:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea193133-13gsands_nurix.htm SC 13G 84872
  Complete submission text file 0001213900-24-013645.txt   86168
Mailing Address
Business Address
SANDS ARTHUR T (Filed by) CIK: 0001134106 (see all company filings)

Type: SC 13G

Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G | Act: 34 | File No.: 005-91591 | Film No.: 24632459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)